project id: TCGA-MESO; case submitter id: TCGA-UT-A88D; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.39; rna integrity number: 8.5; age at index: 66; days to birth: -24300; days to death: 823; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1946; age at diagnosis: 24300; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 756.0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9052/3; primary diagnosis: Epithelioid mesothelioma, malignant; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-UT-A88D-01B-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;